totalbiopharma.com Report : Visit Site

Technical data of the totalbiopharma.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host totalbiopharma.com. Currently, hosted in United Kingdom and its service provider is Terrapinn Holdings Ltd .

the related websites

licata.co.uk wagamama.com abelandcole.co.uk telegraph.co.uk vitacost.com accessdata.fda.gov waitrose.com mysupermarket.co.uk whitehouse.gov crueltyfreeinternational.org 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Microsoft-IIS/7.5 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

total biopharma - innovation and strategy for pharmaceutical, biotech and r&d total biopharma total biopharma navigation r&d drug discovery clinical trials manufacturing regulation & compliance pricing & market access engagement & marketing partnering & investment orphan drugs press releases whitepapers advertise evidera: market access consulting services with rigorous, evolving, and heterogeneous payer evaluation criteria, challenging price negotiations, and a dynamic competitive environment, manufacturers need to prepare their market access strategy early in the product life cycle and assess often to ensure optimal access. evidera is ideally positioned to help you create evidence-optimized value strategies to achieve your product access, price and reimbursement goals. our team brings … read more #evidera #pharmapricing evidence hta pharmacovigilance reimbursement astrazeneca success story with sinequa: cognitive search and analytics platform as a leading biopharmaceutical company, ever wonder how you could unify your siloed data across geographies and business units to extract valuable & contextual insights? for astrazeneca, accuracy, efficiency, and real-time results and insights were priorities to foster cooperation in r&d, drive innovation, accelerate research, catalyze drug repositioning and shorten drug time-to-market. this idc case study report “agile information discovery at … read more #bigdata #biodata astrazeneca r&d sinequa white paper: bluebee data security and compliance bluebee offers a global bio-informatics platform to process, analyze, share and store genomics data. with a private cloud service, bluebee supports users in clinical diagnostics, therapeutics and research with advanced analytics for genomic data driven medicine. designed for cross-functional teams of clinicians and life science researchers the bluebee platform effectively centralizes and manages genomics data processes and storage. bluebee’s multi-layered … read more #biodata bioinformatics biotech bluebee congress data genomics pharma security terrapinn sme bioinformatics forum 2017 how can your company make the most of public molecular data resources? find out at our event for small and medium-sized enterprises (smes), 1 november on the wellcome genome campus in hinxton, cambridge. you’ll meet experts from embl-ebi, the medicines discovery catapult, open targets and many others that focus on bioinformatics, biomedical and biotechnology r&d. https://www.ebi.ac.uk/about/events/2017/sme-bioinformatics-forum-2017 interview with the president of the european institute for innovation through health data the interview was conducted by the dnadigest team (dnadigest.org) dipak kalra is the president of the european institute for innovation through health data (i~hd). he is also a professor of health informatics at university college london, and affiliated with university of gent. he has worked on the clinical, ethical and legal requirements for electronic health records and on the development of international interoperability standards and will present … read more #bigdata #clinical #dnadigest data genetics genomics health informatics ai in pharmacovigilance — re-imagining the icsr processing over the last few decades, we have seen a spurt of medicines approved by regulatory authorities which have necessitated an increase in the need for monitoring drugs. pharmacovigilance, is an arm of medical science which deals with gathering, monitoring and assessing the safety of drugs. it has gained increased focus and prominence, over the last decade. it’s thus not a … read more #healthcare #icsr ai artificial intelligence data digital health machine learning pharma tcs re-imagining drug safety powered by genomics, information integration and emerging technologies || whitepaper by tata consultancy services. pub. 17/08/2017 abstract scientific advancements, emerging technologies, and extensive information have created new opportunities for modernizing drug safety. simultaneously, the pharmacovigilance regulatory landscape is shifting to ensure improved safety for patients. this is the time to reimagine the drug safety sector to transform it into an advanced, proactive and patient-centric practice. introduction the global … read more #healthcare disease drug safety emerging technologies genomics pharmacovigilance tcs whitepaper [[whitepaper]] development of robust processes for large scale antibody-drug conjugation antibody-drug conjugates (adcs) represent a potent therapeutic for targeted delivery of toxins to specific cell types. adcs are composed of a moncolonal antibody (mab) conjugated to a drug molecule via a linker. the use of mabs results in the delivery of the cytotoxic payload to only the targeted cell type, and because of this adcs have shown promise as an … read more adc's americas antibody congress antibody drug conjugates algorics announces latest version of acuity analytics platform algorics announces latest version of acuity analytics platform enhancing the industry’s first end-to-end platform for risk based monitoring acuity now features enhanced site monitoring support, full tracking of insights into actions, and japanese localization houston, tx, usa, for immediate release: 15 march, 2017. algorics, a provider of cloud-based innovative clinical analytics solutions and software for the global life sciences industry, … read more hot topics in pharma and orphan drugs by christina poschen i attended this year’s pharma pricing and market access conference in london with attendees across the pharmaceutical industry, payer and hta bodies and patient representatives. while following the talks, panel discussions and roundtable debates, a few overarching key topics crystallised: – germany – amnog changes amnog, the german pharmaceutical law is regularly adapted to changes in the … read more #global pricing #orphan durgs #ppma amnog congress cro drugs hta market access pharma pricing terrapinn page 1 of 257 1 2 3 ... 257 → search our events phar-east 2018 sectors antibodies stem cells cell culture generics biosimilars oncology antibodies toggle the widgetbar phar-east 2018

URL analysis for totalbiopharma.com

http://www.totalbiopharma.com/tag/americas-antibody-congress/
http://www.totalbiopharma.com/tag/machine-learning/
http://www.totalbiopharma.com/category/biologic-manufacturing/
http://www.totalbiopharma.com/2017/08/17/re-imagining-drug-safety-powered-genomics-information-integration-emerging-technologies-2/
http://www.totalbiopharma.com/usadvertise/
http://www.totalbiopharma.com/category/generics-2/
http://www.totalbiopharma.com/2017/11/17/astrazeneca-success-story-sinequa-cognitive-search-analytics-platform/
http://www.totalbiopharma.com/2017/04/28/whitepaper-development-robust-processes-large-scale-antibody-drug-conjugation/
http://www.totalbiopharma.com/tag/market-access/
http://www.totalbiopharma.com/category/regulation-and-government/
http://www.totalbiopharma.com/tag/artificial-intelligence/
http://www.totalbiopharma.com/2017/10/25/sme-bioinformatics-forum-2017/
http://www.totalbiopharma.com/tag/ai/
http://www.totalbiopharma.com/tag/bioinformatics/
http://www.totalbiopharma.com/tag/data/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: TOTALBIOPHARMA.COM
Registry Domain ID: 1838076218_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ascio.com
Registrar URL: http://www.ascio.com
Updated Date: 2016-11-09T22:45:52Z
Creation Date: 2013-12-05T19:12:58Z
Registry Expiry Date: 2017-12-05T19:12:58Z
Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
Registrar IANA ID: 106
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +442070159370
Domain Status: ok https://icann.org/epp#ok
Name Server: NS.MISTRAL.CO.UK
Name Server: NS2.MISTRAL.CO.UK
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-09-13T13:59:36Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =totalbiopharma.com

  PORT 43

  TYPE domain

DOMAIN

  NAME totalbiopharma.com

  CHANGED 2016-11-09

  CREATED 2013-12-05

STATUS
ok https://icann.org/epp#ok

NSERVER

  NS.MISTRAL.CO.UK 195.184.229.229

  NS2.MISTRAL.CO.UK 195.184.245.245

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .